No insider purchases or sales are on record for NORTHWEST BIOTHERAPEUTICS INC in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $1.4M | $1.4M | $1.9M | $1.7M |
| OPERATING INCOME | $-59.9M | $-66.5M | $-55.5M | $-67.2M |
| NET INCOME | $-60.2M | $-83.8M | $-62.6M | $-105.0M |
| EPS (DILUTED) | -0.04 | -0.07 | -0.06 | -0.10 |
| OPERATING CASH FLOW | $-44.8M | $-57.0M | $-53.6M | $-52.8M |
| CASH | $3.0M | $2.2M | $2.1M | $7.0M |
| LONG-TERM DEBT | $60.0M | $62.7M | $40.8M | $21.5M |
No password to create and no card required. We store your email address and nothing else.